Trt/cardiovascular outcomes

[madman]

JAMA Internal Medicine, February 17,2017

View attachment jamainternal_Cheetham_2017_oi_160129.pdf

 

[Will Brink]

JAMA Internal Medicine, February 17,2017

View attachment 3265

All coming up win!

Key Points

Question What are the cardiovascular risks of testosterone
replacement therapy (TRT) in men with androgen deficiency?

Findings When use in androgen-deficient men with documented
low morning testosterone levels, TRT was not associated with an
increased risk of cardiovascular outcomes. During long-term
follow-up the risk of cardiovascular outcomes was lower in
testosterone-treated men.

Meaning These findings support the use of TRT in
androgen-deficient men.